VLT-015 in Patients With Schizophrenia
Clinical trial NCT05516121 · COMPLETED
Trial details
- NCT number
- NCT05516121
- Sponsor
- CF Pharma, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.